4basebio PLC (4BB.L) LSE

725.00

+0(+0.00%)

Updated at September 26 03:12PM

Currency In GBp

4basebio PLC

Address

25 Norman Way

Cambridge, CB24 5QE

United Kingdom of Great Britain and Northern Ireland

Phone

44 1223 967 943

Sector

Healthcare

Industry

Biotechnology

Employees

101

First IPO Date

February 17, 2021

Key Executives

NameTitlePayYear Born
Dr. Heikki Lanckriet Ph.D.Chief Executive Officer, Chief Scientific Officer & Executive Director441,2001977
Mr. David RothChief Financial Officer, Company Secretary & Executive Director317,9001967
Mr. Gabe LongoriaChief Commercial Officer0N/A
Ms. Amy WalkerChief Operating Officer & Director0N/A

Description

4basebio PLC engages in the design, development, manufacturing, and supply of synthetic DNA and RNA products, and targeted non-viral vector solutions in the United States, Europe, and internationally. The company provides research kits, bulk enzymes, and other products, as well as licensing services; and AVV manufacturing services. It serves biotech, pharma, and contract development and manufacturing organization customers. The company was formerly known as 4basebio UK Societas and changed its name to 4basebio PLC in July 2021. 4basebio PLC was incorporated in 2020 and is based in Cambridge, United Kingdom.